Back
Smith-Midland Vs. MoonLake Immunotherapeutics Industry Stock Comparison
Sell
45
SMID
Smith-Midland
Last Price:
36.76
Seasonality Move:
6.8%
Buy
77
MLTX
MoonLake Immunotherapeutics
Last Price:
51.00
Seasonality Move:
10.4%
Sell
45
Smith-Midland (SMID)
is a Sell
Is Smith-Midland a Buy, Sell or Hold?
- The current Smith-Midland [SMID] share price is $34.25. The Score for SMID is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- SMID is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
77
MoonLake Immunotherapeutics (MLTX)
is a Buy
Is MoonLake Immunotherapeutics a Buy, Sell or Hold?
- The current MoonLake Immunotherapeutics [MLTX] share price is $49.98. The Score for MLTX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
- MLTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SMID Stock Price Chart
What is Smith-Midland's stock price today?
-
The Smith-Midland share price today is $34.25
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SMID is experiencing selling pressure, which indicates risk of future bearish movement.
MLTX Stock Price Chart
What is MoonLake Immunotherapeutics's stock price today?
-
The MoonLake Immunotherapeutics share price today is $49.98
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MLTX is experiencing selling pressure, which indicates risk of future bearish movement.
SMID Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.39 | Buy |
| Relative Strength Index (14 RSI): | 55.53 | Buy |
| Chaikin Money Flow: | -14476 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.3 - 34.6) | Buy |
| Bollinger Bands (100): | (29.69 - 36.09) | Buy |
MLTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.94 | Buy |
| Relative Strength Index (14 RSI): | 60.12 | Buy |
| Chaikin Money Flow: | -227803 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.08 - 49.38) | Buy |
| Bollinger Bands (100): | (40.67 - 46.95) | Buy |
SMID Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.03 | Buy |
| 20-day SMA: | 33.02 | Buy |
| 50-day SMA: | 31.67 | Buy |
| 200-day SMA: | 36.36 | Sell |
| 8-day EMA: | 33.05 | Buy |
| 20-day EMA: | 32.57 | Buy |
| 50-day EMA: | 32.35 | Buy |
| 200-day EMA: | 32.74 | Buy |
MLTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.94 | Buy |
| 20-day SMA: | 47.97 | Buy |
| 50-day SMA: | 46.19 | Buy |
| 200-day SMA: | 48.37 | Buy |
| 8-day EMA: | 48.74 | Buy |
| 20-day EMA: | 47.69 | Buy |
| 50-day EMA: | 46.26 | Buy |
| 200-day EMA: | 45.63 | Buy |
Smith-Midland Earnings Growth & SMID Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
MoonLake Immunotherapeutics Earnings Growth & MLTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.20 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.79 per share.
Smith-Midland Technical Analysis
| Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
MoonLake Immunotherapeutics Technical Analysis
| Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||